Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-03629-2 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Amin Tajerian und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Arak University of Medical Sciences, Arak, Iran. Hauptthemen laut MEDLINE: Omalizumab, Chronic Urticaria, Cost-Benefit Analysis. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Arak University of Medical Sciences, Arak, Iran.
- Department of Pediatrics, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
- Department of Allergy and Clinical Immunology, Mashhad University of Medical Sciences, Mashhad, Iran.
- Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Allergy and Clinical Immunology, Mashhad University of Medical Sciences, Mashhad, Iran. faridzadeha2@mums.ac.ir.
ORCID-Profile: Arezoo Faridzadeh
Zitieren
APA
Tajerian, A., Pourvali, A., Khoshkhui, M., Movahedi Aliabadi, M., Mobinikhaledi, M., & Faridzadeh, A. (2024). Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03629-2
Vancouver
Tajerian A, Pourvali A, Khoshkhui M, Movahedi Aliabadi M, Mobinikhaledi M, Faridzadeh A. Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03629-2
BibTeX
@article{Tajerian2024,
author = {Tajerian, Amin and Pourvali, Ali and Khoshkhui, Maryam and Movahedi Aliabadi, Mehraneh and Mobinikhaledi, Mahya and Faridzadeh, Arezoo},
title = {Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-03629-2}
}
EUVIMED